GGrantIndex
← Leaderboards

Ben Z Stanger

Massachusetts General Hospital

Google Scholar ↗PubMed ↗ORCID ↗
$14,778,829
Attributed
$29,833,293
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.6M · FY2005–25
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$29,833,293 · 11

By mechanism

R01$15,887,681 · 5
UC4$5,071,418 · 1
UH3$3,372,768 · 1
DP2$2,429,587 · 1
UG3$2,266,564 · 1
K08$649,350 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Cells”

Research focus

CellsMolecularSourceInnovationIn VivoInsightImmuneHeterogeneityResponseTumorPancreatic Ductal AdenocarcinomaIn VitroMalignant NeoplasmsPathway InteractionsTumor MicroenvironmentPhenotypeExhibitsProgramsCancer CellGenetically Engineered MouseSignal TransductionBlood VesselsBiologyT-Lymphocyte

Grant awards (49)

Stromal and vascular inputs into pancreatic cancer tumor neighborhoods$617,725
R01 · FY2025 · CA · contact PI
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$557,401
R01 · FY2025 · CA
Stromal and vascular inputs into pancreatic cancer tumor neighborhoods$624,279
R01 · FY2024 · CA · contact PI
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$529,533
R01 · FY2024 · CA
Stromal and vascular inputs into pancreatic cancer tumor neighborhoods$68,500
R01 · FY2024 · CA · contact PI
Microphysiological systems for modeling autoimmunity in type 1 diabetes$1,121,769
UH3 · FY2023 · DK · contact PI
Stromal and vascular inputs into pancreatic cancer tumor neighborhoods$664,259
R01 · FY2023 · CA · contact PI
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$544,659
R01 · FY2023 · CA
Microphysiological systems for modeling autoimmunity in type 1 diabetes$1,124,415
UH3 · FY2022 · DK · contact PI
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer$644,986
R01 · FY2022 · CA
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$462,168
R01 · FY2022 · CA
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer$103,540
R01 · FY2022 · CA · contact PI
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$103,503
R01 · FY2022 · CA
Microphysiological systems for modeling autoimmunity in type 1 diabetes$1,126,584
UH3 · FY2021 · DK · contact PI
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer$657,258
R01 · FY2021 · CA
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$598,666
R01 · FY2021 · CA
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer$162,333
R01 · FY2021 · CA
Microphysiological systems for modeling autoimmunity in type 1 diabetes$1,125,532
UG3 · FY2020 · DK · contact PI
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer$820,052
R01 · FY2020 · CA
Mechanisms of bile duct reprogramming$507,802
R01 · FY2020 · DK · contact PI
Microphysiological systems for modeling autoimmunity in type 1 diabetes$1,141,032
UG3 · FY2019 · DK · contact PI
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer$640,513
R01 · FY2019 · CA
Mechanisms of bile duct reprogramming$507,802
R01 · FY2019 · DK · contact PI
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer$662,729
R01 · FY2018 · CA
Mechanisms of bile duct reprogramming$507,802
R01 · FY2018 · DK · contact PI
Mechanisms of bile duct reprogramming$507,802
R01 · FY2017 · DK · contact PI
Immunobiology and immunotherapy of pancreatic cancer$681,452
R01 · FY2016 · CA
Mechanisms of bile duct reprogramming$522,802
R01 · FY2016 · DK · contact PI
A vascularized 3D biomimetic for islet function and physiology$72,000
UC4 · FY2016 · DK · contact PI
Immunobiology and immunotherapy of pancreatic cancer$635,533
R01 · FY2015 · CA
A vascularized 3D biomimetic for islet function and physiology$4,999,418
UC4 · FY2014 · DK · contact PI
Immunobiology and immunotherapy of pancreatic cancer$604,414
R01 · FY2014 · CA
Immunobiology and immunotherapy of pancreatic cancer$585,722
R01 · FY2013 · CA
Mechanisms of Bile Duct Morphogenesis$322,470
R01 · FY2013 · DK · contact PI
Immunobiology and immunotherapy of pancreatic cancer$623,108
R01 · FY2012 · CA
Mechanisms of Bile Duct Morphogenesis$334,367
R01 · FY2012 · DK · contact PI
Mechanisms of Bile Duct Morphogenesis$334,562
R01 · FY2011 · DK · contact PI
Mechanisms of Bile Duct Morphogenesis$375,136
R01 · FY2010 · DK · contact PI
AN IN VIVO APPROACH TO CELL-BASED THERAPY FOR TYPE I DIABETES$67,087
DP2 · FY2010 · DK · contact PI
Mechanisms of Bile Duct Morphogenesis$374,803
R01 · FY2009 · DK · contact PI
AN IN VIVO APPROACH TO CELL-BASED THERAPY FOR TYPE I DIABETES$2,362,500
DP2 · FY2008 · DK · contact PI
Notch Signaling and Cell Fate in Embryonic and Adult Liver$77,175
R03 · FY2008 · DK · contact PI
Molecular Regulation of Pancreas Cell Fate Determination$129,870
K08 · FY2007 · DK · contact PI
Notch Signaling and Cell Fate in Embryonic and Adult Liver$78,750
R03 · FY2007 · DK · contact PI
Molecular Regulation of Pancreas Cell Fate Determination$71,463
K08 · FY2006 · DK · contact PI
Molecular Regulation of Pancreas Cell Fate Determination$58,407
K08 · FY2006 · DK · contact PI
Molecular Regulation of Pancreas Cell Fate Determination$129,870
K08 · FY2005 · DK
Molecular Regulation of Pancreas Cell Fate Determination$129,870
K08 · FY2004 · DK
Molecular Regulation of Pancreas Cell Fate Determination$129,870
K08 · FY2003 · DK